伊藤量基

イトウトモキ | ITO TOMOKI

所属機関・部署：
職名：教授

研究分野 (2件)：膠原病、アレルギー内科学 , 免疫学

競争的資金等の研究課題 (10件)：

全件表示

論文 (154件)：

Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia after SARS-CoV-2 Omicron infection frequently induced physical functional decline in Japan. Journal of medical microbiology. 2024. 73. 8. 001872
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia. Respiratory investigation. 2024. 62. 3. 384-387
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024. 30. 5. 463-466
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?. Respiratory investigation. 2024. 62. 2. 187-191
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Functional decline at 1 year in hospitalized elderly pneumonia with SARS-CoV-2 Omicron variant: Comparison with the ancestral strain and Alpha variant. Influenza and other respiratory viruses. 2024. 18. 2. e13251

MISC (77件)：

Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Efficacy of ensitrelvir for cough due to COVID-19 Omicron variant in medical healthcare workers. Antimicrobial agents and chemotherapy. 2024. 68. 10. e0106424
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia was the most frequent cause of death in older patients with SARS-CoV-2 omicron-related pneumonia in Japan. Journal of the American Geriatrics Society. 2024. 72. 7. 2234-2236
Yuka Ishii, Jun Ichikawa, Masaya Okada, Kazuyoshi Ishii and Tomoki Ito. Successful treatment of Dara sc-CyBorD in a patient with AL amiyloidosis and severe heart failure. International Journal of Myeloma 14(1):5-11,2024. 2024. 14. 1. 5-11
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, Kurahashi S, Kagoo T, Tanimoto K, Saotome S, et al. Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology. 2024. 99. 2. E55-E59
Ishiura Y, Nomura S, Ishii Y, Imai K, Sawai Y, Tamaki T, Shimizu T, Miyashita N, Ito T. Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough. International medical case reports journal. 2023. 16. 4. 497-501

書籍 (9件)：

講演・口頭発表等 (346件)：

Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia due to Myelofibrosis
(ASH2023 第65回米国血液学会 2023)
LONG-TERM TREATMENT WITH FOSTAMATINIB IN JAPANESE PATIENTS WITH PRIMARY ITP
(ASH2023 第66回米国血液学会 2023)
Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera
(ASH2023 第65回米国血液学会 2023)
Thrombotic and bleeding events in Japanese Adolescent and Young Adult PV and ET - Results from Japanese multicenter retrospective study -
(ASH2023 第65回米国血液学会 2023)
Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study
(65th American Society of Hematology Annual Meeting and Exposition 2023)

経歴 (1件)：

委員歴 (5件)：

受賞 (1件)：

所属学会 (5件)：

日本リウマチ学会 , 日本免疫学会 , 日本臨床血液学会 , 日本リンパ網内系学会 , 日本血液学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

伊藤 量基